Company retains a visionary collaborator for the launch of their innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Reza Forghani, MD, PhD has accepted to serve on neuropacs’ Board of Clinical Advisor, effective immediately. Dr. Forghani is a member of the…

Read more about Neuropacs Enrolls Dr. Reza Forghani to its Board of Clinical Advisors

Company retains an influential clinical collaborator for the launch of its innovative software for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Adolfo Ramirez-Zamora, MD, has accepted to serve on neuropacs’ Board of Clinical Advisors, effective immediately. Dr. Ramirez-Zamora is a Professor of Neurology,…

Read more about Neuropacs Enrolls Dr. Ramirez-Zamora on its Board of Clinical Advisors

GAINESVILLE, FL – neuropacsTM, a leading innovator in medical diagnostics, is excited to announce the acquisition of an exclusive option agreement for a groundbreaking diagnostic technology for Alzheimer’s disease developed at the University of Florida. This innovative technology, spearheaded by neuropacsTM‘s Co-Founder and Chief Scientific Officer, David Vaillancourt, has the potential to revolutionize early detection…

Read more about Revolutionary Alzheimer’s Diagnostic Technology Option Agreement Secured by neuropacs in Collaboration with UF

GAINESVILLE, FL – Michael Okun, MD has accepted to serve on neuropacs’ Board of Clinical Advisors and will not be compensated, to maintain clinical independence and ensure no actual or perceived conflicts of interest.

Read more about Dr. Michael Okun Joins Neuropacs’ Board of Clinical Advisors

Company grows management team in preparation for the launch of its AI-driven algorithm for the diagnosis of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Mr. Dwight L. Hulse MBA, MPA, CPA/CITP, CGMA, CA(BZ) will serve as their fractional Chief Financial Officer, effective immediately. Mr. Hulse is…

Read more about Neuropacs appoints Dwight L. Hulse as their fractional CFO

Company grows management team in preparation for the launch of their AI-driven algorithm for the diagnostic of Parkinson’s Disease. GAINESVILLE, FL – neuropacsTM, a leading innovator in AI-driven neurological diagnostics, today announced that Martin Handfield, MS, PhD, will serve as President and Chief Executive Officer, effective immediately. Dr. Handfield is a local serial entrepreneur, having…

Read more about Neuropacs Appoints Martin Handfield as President and CEO

FOR IMMEDIATE RELEASE GAINESVILLE, FL. Automated Imaging Diagnostics, a leading innovator in medical technology, is proud to announce that its flagship product, neuropacsTM, has been awarded a Phase I Small Business Technology Transfer (STTR) grant from the National Institutes of Health, an NIH institute. This grant will drive forward the evolution of neuropacsTM and the…

Read more about Phase I STTR grant from NIH/NINDS to Enhance neuropacs Technology for Parkinsonism Classification